Eurand Overview
- Year Founded
-
1969
- Status
-
Acquired/Merged
- Employees
-
620
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
- Investments
-
2
Eurand General Information
Description
Manufacturer and developer of pharmaceutical and biopharmaceutical products. The company has applied its technologies to drug products in a range of therapeutic areas, including cardiovascular, gastrointestinal, pain, nutrition and respiratory.
Contact Information
Corporate Office
- 123 Olympic Plaza
- Fred. Roeskestraat
- 1076 EE Amsterdam
- Netherlands
Corporate Office
- 123 Olympic Plaza
- Fred. Roeskestraat
- 1076 EE Amsterdam
- Netherlands
Eurand Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Eurand Signals
Eurand Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Eurand Investments (2)
Eurand’s most recent deal was a Buyout/LBO with SourceCF for . The deal was made on 03-Dec-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SourceCF | 03-Dec-2007 | Buyout/LBO | Specialty Retail | ||
| Immunex | 20-May-1999 | Convertible Debt | Biotechnology |
Eurand Exits (1)
Eurand’s most recent exit was on 20-May-1999 from Immunex. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Immunex | 20-May-1999 | Completed |
|
Eurand FAQs
-
When was Eurand founded?
Eurand was founded in 1969.
-
Where is Eurand headquartered?
Eurand is headquartered in Amsterdam, Netherlands.
-
What is the size of Eurand?
Eurand has 620 total employees.
-
What industry is Eurand in?
Eurand’s primary industry is Pharmaceuticals.
-
Is Eurand a private or public company?
Eurand is a Private company.
-
What is the current valuation of Eurand?
The current valuation of Eurand is .
-
What is Eurand’s current revenue?
The current revenue for Eurand is .
-
How much funding has Eurand raised over time?
Eurand has raised $104M.
-
Who are Eurand’s investors?
Warburg Pincus has invested in Eurand.
-
When was Eurand acquired?
Eurand was acquired on 11-Feb-2011.
-
Who acquired Eurand?
Eurand was acquired by Aptalis Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process